pemetrexed Clinical Research Trials

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (3)

Phase 0 (1)
Phase 2 (1)
Phase 3 (1)

Interventional (2)

National Cancer Institute (NCI) (1)
National Hospital Organization Nagoya Medical Center (1)

No (3)

No (3)

Adult (18+) (3)
Pediatric (Under 18) (1)

I am/have/had

I am/have/hadmeasurable disease

I am/have/hadnon-small cell lung cancer

I am/have/hadlung cancer

I am/have/hadsmall cell lung cancer

I am/have/hadcancer

I am/have/hadmetastasis

I am/have/hadsquamous non-small cell lung cancer

I am/have/hadnon-squamous non-small cell lung cancer

I am/have/hadcarcinoma

I am/have/hadneutrophil count

I am/have/hadadjuvant therapy

I am/have/hadplatelet count

I am/have/hadlung carcinoma

I am/have/hadrecurrent non-small cell lung cancer

I am/have/hadchromosomal translocation

I am/have/hadantiretroviral therapy

I am/have/hadcisplatin/gemcitabine

I am/have/hadimmunohistochemistry

I am/have/hadimmunodeficiency

I am/have/hadsquamous cell carcinoma

added new label for I am/have/had

I am looking for

I am looking forpemetrexed

I am looking forcarboplatin

I am looking forcisplatin

I am looking forimmunomodulators

I am looking forpembrolizumab

I am looking forgemcitabine

I am looking formonoclonal antibodies

I am looking forpaclitaxel

I am looking formonoclonal protein

I am looking foradjuvant

added new label for I am looking for

Advanced Filters

Found 3 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

A081801 / RLUN20119 / ALCHEMIST-IO (ACCIO) / Yuhchyau Chen

Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor …

0 views
19 Feb, 2024
1 location

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer ALCHEMIST Chemo-IO Study

Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Drugs used in chemotherapy, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth …

antiretroviral therapy

stage ii lung cancer ajcc v7

cisplatin/gemcitabine

stage ii lung squamous cell carcinoma ajcc v7

gemcitabine

0 views
19 Feb, 2024

Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901

To evaluate the efficacy and safety of Pembrolizumab + Pemetrexed in elderly patients with non-squamous non-small cell lung cancer with Programmed cell death (PD) -ligand1 (L1) tumor proportion score (TPS) of less than 50%.

immunomodulators

measurable disease

recurrent nsclc

small cell lung cancer

lung cancer

0 views
19 Feb, 2024